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Human mutations in the cytoplasmic C-terminal
domain of Slack sodium-activated potassium (KNa)
channels result in childhood epilepsy with severe in-
tellectual disability. Slack currents can be increased
by pharmacological activators or by phosphorylation
of a Slack C-terminal residue by protein kinase C. Us-
ing an optical biosensor assay, we find that Slack
channel stimulation in neurons or transfected cells
produces loss of mass near the plasma membrane.
Slack mutants associated with intellectual disability
fail to trigger any change in mass. The loss of mass
results from the dissociation of the protein phospha-
tase 1 (PP1) targeting protein, Phactr-1, from the
channel. Phactr1 dissociation is specific to wild-
type Slack channels and is not observed when
related potassium channels are stimulated. Our find-
ings suggest that Slack channels are coupled to
cytoplasmic signaling pathways and that dysregula-
tion of this coupling may trigger the aberrant intellec-
tual development associated with specific childhood
epilepsies.
INTRODUCTION
The Na+-activated K+ channel Slack (KNa1.1, KCNT1, SLO2.2) is
widely distributed throughout the nervous system (Kaczmarek,
2013). KNa currents in neurons and in Slack-transfected cells
are regulated by several pathways, including phosphorylation
of a serine residue (S407) in cytoplasmic C-terminal domain,
which results in a stimulation of current amplitude (Barcia
et al., 2012; Santi et al., 2006). The large cytoplasmic C-terminal
domain of Slack also interacts with the fragile X mental retarda-Cell R
This is an open access article undtion protein (FMRP), a RNA-binding protein that regulates activ-
ity-dependent protein translation (Brown et al., 2010; Zhang
et al., 2012). The interaction of Slack with FMRP also stimulates
channel activity. The amplitude of Slack currents can also be
stimulated by a number of pharmacological agents, including bi-
thionol and niclosamide (Biton et al., 2012; Yang et al., 2006).
Mutations in ion channels can produce disorders of excit-
ability, such as childhood epileptic seizures. Mutations in Slack
have been described in malignant migrating partial seizures of
infancy (MMPSI), a condition that produces infantile seizures
coupled with very severe intellectual disability (Barcia et al.,
2012; Kim et al., 2014). The majority of these mutations produce
single amino acid substitutions within the cytoplasmic C-termi-
nal domain of Slack. These gain-of-function mutations increase
Slack current amplitude (Kim et al., 2014).
It is unclear, however, why some epilepsy-associated muta-
tions produce little intellectual deficit, while others, such as those
in Slack, result in severe intellectual disability. Similar gain-of
function mutations in another FMRP-interacting channel, the
closely related Ca2+-activated K+ channel BK (KCNMA1, SLO1)
(Deng et al., 2013), also produce seizures but do not result in
intellectual disability (Du et al., 2005; N’Gouemo, 2014). This
suggests that differences in the effects of these mutations on
interactions with cytoplasmic signaling pathways, rather than
current amplitude, may contribute to the differences in intellec-
tual function.
We have found that the large cytoplasmic domain of Slack in-
teracts with a cytoplasmic signaling protein, Phactr1 (phospha-
tase and actin regulator 1). Under normal conditions, stimulation
of Slack channels causes Phactr1 to dissociate from the chan-
nel, resulting in a measurable loss of mass close to the plasma
membrane of neurons. Mutant disease-causing Slack channels,
however, fail to associate/dissociate with Phactr1. Our results
suggest that failure to interact appropriately with its cytosolic
signaling partners may underlie the severe intellectual disability
associated with Slack mutations.eports 16, 2281–2288, August 30, 2016 ª 2016 The Authors. 2281
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
RESULTS
Activation of Slack Decreases Mass at the Plasma
Membrane
To monitor the interactions of Slack channels with its potential
cytoplasmic partners in real-time within living cells, we used
resonance-wavelength grating (RWG) optical biosensors, a
technique that has been used to monitor the activation of G pro-
tein coupled receptors (Fang et al., 2007; Fleming and Kacz-
marek, 2009; Lee, 2009). When cells adhere to these optical bio-
sensors, changes in mass within 150 nm of the biosensor alter
the peak intensity of the reflected wavelengths of resonant light.
Decreases or increases in protein density near the plasmamem-
brane produce decreases or increases in the relative index of
refraction, respectively (Fleming et al., 2014) (Figure 1A). RWG
optical biosensors are sensitive enough to detect the binding
of small molecules to proteins, providing a ready assay to detect
the much larger changes resulting from the association/dissoci-
ation of channels with other proteins (Daghestani and Day, 2010;
Lin et al., 2002). We first tested the actions of bithionol and niclo-
samide, two pharmacological activators that substantially
enhance Slack currents (Biton et al., 2012; Yang et al., 2006).
Treatment of Slack-expressing HEK293T cells with the Slo family
channel activator bithionol (10 mM) (Yang et al., 2006) produced a
progressive decrease in mass at the plasma membrane over
several minutes following application (Figure 1B). The decrease
in mass was sustained over the course of these experiments. Bi-
thionol had no effect on untransfected cells, and DMSO vehicle
had no significant effect on either untransfected or Slack-ex-
pressing cells (Figure 1B). Similar results were obtained using
niclosamide (Biton et al., 2012) (Figure 1C).
The observed decrease in mass upon channel stimulation is
specific to Slack channel stimulation and not a general conse-
quence of increased K+ conductance. Bithionol is a potent acti-
vator of other Slo family potassium channels, including BK chan-
nels and the very closely related Na+-activated K+ channel Slick
(KNa1.2, KCNT2, Slo2.1) (Yang et al., 2006). Changes in mass
were, however, evoked only in Slack- but not in BK- or Slick-ex-
pressing cells (Figure 1D). As a further test to determine whether
ion flux plays a role in mass change, we pretreated Slack-ex-
pressing cells with the known Slack pore blocker Ba2+ (1 mM)
(Bhattacharjee et al., 2003) for 1 hr prior to bithionol (10 mM) addi-
tion. Blocking K+ flux had no effect on the observed signal (Fig-
ure 1E). Changes in mass at the surface of the biosensor could
reflect Slack-dependent changes in cell morphology or cellular
movement. To exclude the possibility that the mass change
upon Slack stimulation results from such changes, we pretreated
Slack-expressing cells with the actin polymerization inhibitor
Latrunculin B (2 mM) (Wakatsuki et al., 2001) for 1 hr prior to
channel stimulation by bithionol. Inhibition of actin polymeriza-
tion did not attenuate the observed signal, excluding the possi-
bility that the loss of mass results from actin-mediated changes
in cell morphology (Figure 1F).
To determine whether the Slack-stimulation induced loss of
mass at the plasma membrane is an artifact of heterologous
channel expression in HEK cells, we carried out the same exper-
iment using primary cultures of cortical neurons from wild-type
mice (Figures 1G–1I). These neurons express Slack channels2282 Cell Reports 16, 2281–2288, August 30, 2016endogenously (Bhattacharjee et al., 2002; Brown et al., 2008).
As in the cell line, a similar sustained decrease in mass was
observed upon treatment with the Slack activator niclosamide
(1 mM) (Biton et al., 2012) (Figures 1H and 1I). No significant
change inmasswas, however, produced on treatment of cortical
neurons from animals in which the Slack gene had been deleted
(Lu et al., 2015) (Figures 1G–1I).
Under physiological conditions, the stimulation of Slack oc-
curs upon phosphorylation of residue S407 in the cytoplasmic
C terminus by protein kinase C (PKC), leading to a 2- to 3-fold in-
crease in current (Barcia et al., 2012; Santi et al., 2006). Even in
untransfected cells, however, treatment with PKC activators
such as TPA (12-O-Tetradecanoylphorbol-13-acetate, 100 nM)
leads to PKC translocation to the plasma membrane, increasing
mass measured at the biosensor (Figure 2A). A change in mass
produced by Slack stimulation in response to PKC activation
was therefore calculated as the difference between the mass
change produced by TPA in untransfected and Slack-expressing
cells (Figure 2B). We found that, like bithionol treatment, stimula-
tion of Slack channels by TPA led to a decrease in mass at the
membrane (Figure 2B) and that the stimulatory effects of bithio-
nol and phosphorylation are additive (Figures S1A and S1B). Mu-
tation of serine 407 to an alanine abolished differences between
Slack-expressing and control cells (Figures 2A and 2B), without
altering bithionol sensitivity (Figures S1C and S1D). This indi-
cates that, like bithionol, stimulation of Slack channels by phos-
phorylation at S407 decreases Slack-associated mass at the
plasma membrane.
Slack-Induced Changes in Mass Are Absent in Slack
MMPSI Mutants
To determine whether human Slack mutations that produce in-
fantile seizures coupled to severe intellectual disability alter the
normal pattern of mass distribution upon channel stimulation,
we studied two previously described MMPSI mutations, Slack-
R409Q and -A913T (Barcia et al., 2012). Expression of these
mutant channels yield currents that resemble those of wild-
type Slack, but their amplitude is increased by 2- to 3-fold, and
they cannot be further activated by PKC (Barcia et al., 2012).
We first tested their sensitivity to pharmacological stimulation.
Despite the fact that they are insensitive to TPA (Barcia et al.,
2012), the currents of bothmutant channels were activated by bi-
thionol (10 mM) to the same extent as wild-type channels (Fig-
ure 2C). Surprisingly, however, we found that that both mutants
failed to produce any change inmass in response to either bithio-
nol (Figure 2D) or TPA (Figures 2E and 2F). The time course of
changes inmass upon activation of PKC by TPA in cells express-
ing Slack-MMPSI mutant channels was identical to that in cells
transfected with only control vector (Figure S2). The loss of
Slack-associated changes in mass at the plasma membrane
may therefore be linked to the pathogenesis of MMPSI.
Slack Interacts with FMRP, Cyfip1, and Phactr1
In addition to altering ion flux across the plasma membrane, the
activation of ion channels can directly influence cytoplasmic
events through protein-protein interactions between the chan-
nels and cellular signaling molecules (Calhoun and Isom, 2014;
Deng et al., 2013; Ferron et al., 2014; Gross et al., 2011).
Figure 1. Stimulation of Slack Channels Alters Mass Distribution at the Plasma Membrane
(A) Schematic diagram of Slack activation in a cell adherent to the biosensor.
(B) Activation of Slack-expressing, but not untransfected, HEK cells with bithionol (10 mM) produced a sustained decreased in mass near the plasma membrane,
n = 32 wells/condition, p < 0.001.
(C) Changes in mass in Slack-expressing HEK after Slack activation with bithionol (10 mM) or niclosamide (500 nM) (n = 16, p < 0.001).
(D) Stimulation of Slack, but not other Slo channel family members, with bithionol (10 mM) decreases mass near the plasma membrane, n = 24, p < 0.001.
(E) Blocking ion flux through Slack channels with Ba2+ (1 mM) does not alter the signal upon channel activation, n = 16.
(F) Latrunculin B (2 mM) does not alter the signal upon Slack activation by bithionol (10 mM), n = 12.
(G) Slack protein expression is absent in brain synaptosomes isolated from Slack/ mice (n = 3/genotype).
(H and I) Activation of Slack channels in wild-type (WT), but not Slack/, murine cortical neurons decreasesmass near the plasmamembrane (H). Representative
images showing change in mass in cortical neurons with red representing decreases in mass and black representing no change in mass (I). Quantification of (H),
n = 12, p < 0.001.
Error bars ± SEM.
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Figure 2. MMPSI and Phosphorylation Site Slack Mutations Prevent Decreases in Mass upon Channel Activation
(A) Changes in mass measured 30 min after addition of the PKC activator TPA or its inactive analog 4a-phorbol, to untransfected cells or to cells expressing wild-
type (WT) Slack or its phosphorylation site mutant S407A Slack. The increase in mass produced by TPA in untransfected cells or S407A cells is significantly
reduced in cells expressing WT Slack. n = 16, p < 0.001.
(B) The contribution of Slack to the mass change in (A) was calculated by the difference between the positive mass change after TPA addition in untransfected
(black bar, A) and Slack-containing cells (red bar, B).
(C) Percentage increases in Slack current amplitude produced by bithionol (10 mM, 20 min) in Xenopus oocytes expressing WT Slack, or the MMPSI mutants
R409Q Slack or A913T Slack cRNA. n = 3 oocytes/condition.
(D) Slack R409Q and A913T mutant channels produce no change in mass after activation by bithionol (10 mM), n = 16, p < 0.001.
(E) Changes in mass produced by activation of PKC by TPA in R409Q and A913T Slack-expressing cells are not different from those in untransfected (vector
control cells).
(F) Differences in mass change between untransfected and Slack-expressing cells in response to TPA treatment. Mass change in R409Q and A913T mutant
Slack-expressing cells was not different from untransfected cells but significantly different from WT slack cells (n = 16, p < 0.001).
Error bars ± SEM.Previous studies showed that the distal C terminus of Slack inter-
acts with FMRP and that deletion of the Slack C-terminal domain
distal to residue 804 results in functional channels that fail to
interact with FMRP (Brown et al., 2010). We found that deletion
of this same domain abolished the decrease in mass upon chan-
nel stimulation, indicating that this domain is required for the
channel-protein interactions that lead to the loss of mass (Fig-
ure 3A). We therefore carried out experiments to test whether
protein-protein interactions with FMRP or other cytoplasmic fac-
tors were required for the observed mass effects.
To identify proteins other than FMRP that might interact with
the C terminus of Slack, we used the yeast two-hybrid approach
to identify two additional Slack-interacting proteins, Phactr1 and
Cyfip1 (cytoplasmic FMR1-interacting protein 1) (Figure S3). The
interaction of Phactr1 with Slack was confirmed with co-immu-2284 Cell Reports 16, 2281–2288, August 30, 2016nopurification of Slack from transfected HEK cells (Figures 3C
and 3D) and mouse brain (Figure S4), followed by western blot-
ting. Phactr1 did not co-immunoprecipitate with BK channels,
indicating the specificity of this interaction with Slack (Figure 3E).
Phactr1 Is Required for Slack-Dependent Changes in
Mass at the Plasma Membrane
FMRP, Phactr1, and Cyfip1 are all expressed endogenously in
HEK cells. To determine whether one of these proteins is
required for the decrease in mass at the plasma membrane
upon Slack stimulation, we suppressed expression of each
protein using RNAi. Conditions were optimized by detecting
decreased protein expression of the target protein with individ-
ual or small interfering RNAs (siRNAs) in combination (Figure 4A).
A decrease in levels of Phactr1, but not those of FMRP or Cyfip1,
Figure 3. Slack Interacts with Phacr1
(A) The changes in mass produced by PKC activation in cells expressing wild-
type Slack differs from that in cells expressing D804 Slack, which lacks the
distal C terminus, or untransfected cells (n = 16, p < 0.001). Error bars ± SEM.
(B) Data in (A) are plotted as the difference between untransfected cells and
Slack-expressing cells.
(C–F) Phactr1 binds to Slack channels but not BK channels. Cell lysates were
prepared from Slack-Flag (C and D) or BK-Flag (E and F)-expressing cells, and
coimmunoprecipitation was performed using anti-Flag antibodies followed by
western blotting with anti-Phactr1 (C and E) antibodies or anti-Slack (D and F)
antibodies (n = 2/condition). GAPDH loading controls for cell lysates of Slack-
Flag (C) and BK-Flag (E) inputs were performed.strongly suppressed the ability of Slack stimulation to produce a
decrease in mass at the membrane (Figure 4B). RNAi treatments
had no effect on cell viability (Figure 4C). To confirm that Phactr1
is required for changes in mass produced by Slack stimulation in
real neurons, we repeated this experiment using mouse primary
cortical neurons (Figure 4D). In these neurons, as in the HEK
cells, downregulation of Phactr1 strongly suppressed the effects
of Slack stimulation.
Phactr1 regulates the cellular localization of protein phospha-
tase 1 (PP1) (Allen et al., 2004; Wiezlak et al., 2012), and dissoci-
ation of Phactr1, presumably together with PP1, is likely to pro-
mote and maintain phosphorylation of the Slack channel. To
determine whether the activity of PP1 is required for changes
in mass at the plasma membrane, we tested the effects of the
PP1 inhibitor tautomycetin (5 mM), which selectively inhibits
PP1 over Protein Phosphatase 2A (Mitsuhashi et al., 2003).
This agent did not, however, alter changes in mass at the plasma
membrane on Slack stimulation, indicating that PP1 activity per
se is not required (Figure 4E).
The requirement for expression of Phactr1 for the observed
change inmass on stimulation of Slack channels could represent
the physical dissociation of Phactr1 from the channel or could
reflect Phactr1-dependent dissociation of some other factor.
To measure changes in Phactr1/Slack association directly, we
immunoprecipitated Slack channels before and after activation
by TPA and bithionol. Levels of Phactr1 that were detected in
the immunoprecipitate were very greatly reduced after channel
stimulation (Figure 4F), confirming that loss of mass at the
plasma membrane occurs when Phactr1 dissociates from Slack
channels. Thus, PKC translocates to the membrane and phos-
phorylates Slack channels at S407 causing the release the
Phactr1 and subsequent loss of mass at the membrane.
DISCUSSION
Our findings indicate that the cytoplasmic C-terminal of Slack
KNa channels interacts with several cytoplasmic signaling mole-
cules including the phosphatase targeting protein Phactr1. On
stimulation of the activity of Slack channels, either by the activa-
tion of PKC or by pharmacological agents, Phactr1 dissociates
from the channel complex. It is possible that the change in
mass at the plasma membrane that we measure both in trans-
fected cells and cortical neurons in response to channel stimula-
tion reflects the dissociation of other factors in addition to
Phactr1. Nevertheless, suppression of the expression of either
FMRP or Cyfip1 did not alter changes in mass at the membraneCell Reports 16, 2281–2288, August 30, 2016 2285
Figure 4. Phactr1 Is Required for Slack-Induced Changes in Mass following Phosphorylation or Pharmacological Stimulation
(A) Blot showing decreased expression of Slack-associated proteins following RNAi against FMRP, Cyfip1, or Phactr1 inWT Slack-expressing cells. Lanes are as
follows: s, scrambled siRNA negative control; 1 – 3, three different individual siRNAs alone, 4, equimolar combination of the three siRNAs; G, GAPDH positive
control. Bottom blot shows that RNAi against Phactr1 did not decrease Slack expression.
(B) RNAi against Phactr1, but not FMRP or Cyfip1, significantly reduced the mass change produced by bithionol (10 mM) in WT Slack cells (n = 8, p < 0.001, error
bars ± SEM).
(C) RNAi against Slack-associated proteins does not decrease cell viability in a Resazurin assay. A standard curve of cell survival was generated by utilizing
10-fold dilutions of Saponin from 0.1% to 0%, with 0.1% Saponin-treated cells considered no cell survival and 0% Saponin-treated cells considered complete
cell survival, n = 3 wells/condition, Z0 for assay = 0.60.
(D) Changes in mass produced in mouse primary cortical neurons by the Slack activator niclosamide (1 mM) are suppressed in neurons treated with RNAi against
Phactr1 (n = 12, p < 0.01).
(E) Pre-treatment of Slack-B-expressing cells with the PP1 inhibitor tautomycetin (2 mM) does not alter bithionol-induced changes inmass inWT Slack cells (n = 8).
(F) Western blots demonstrating that treatment of WT Slack cells with either bithionol (10 mM) or TPA (100 nM) strongly reduces levels of Phactr1 that can be
co-immunoprecipitated with Slack channels (n = 2/condition).following Slack stimulation, indicating that these interacting pro-
teins are not required for the observed effects.
We have shown that the distal C terminus of Slack is required
for Phactr1/Slack interactions. This sequence of this region of
Slack differs substantially from the corresponding regions in
Slick and BK (Bhattacharjee et al., 2003; Salkoff et al., 2006),
which apparently do not interact with Phactr1. Although the
overall structure of Slack channels has recently been solved
by cryo-electron microscopy (Hite et al., 2015), the distal
cytoplasmic C-terminal region could not be resolved clearly,
providing no insights into how this region may contribute to
Phactr1 biding.
The dissociation of Phactr1 is likely to regulate phosphoryla-
tion of the Slack channel. It may, however, potentially also regu-
late other channel-associated proteins such as FMRP. Alterna-
tively, its dissociation from the channel may allow it to interact
with other membrane or cytoplasmic targets. The disassociation
of Phact1 on channel stimulation may therefore provide a signal2286 Cell Reports 16, 2281–2288, August 30, 2016that links neuronal excitability to downstream signaling path-
ways. The finding that the Phactr1/Slack interaction is entirely
abolished in mutant Slack channels that produce childhood ep-
ilepsy with very severe developmental delay (Kim and Kacz-
marek, 2014) suggests that this pathway may be crucial to
normal neuronal development.EXPERIMENTAL PROCEDURES
Animals
Rodents were handled in accordance with protocols approved by the Yale
University Institutional Animal Care Committee.
Expression Slack-B or Mutant Expression Vectors
Slack-B S407A, R409Q, A913T, and D804 C-terminal truncation mutants were
constructed as previously described (Barcia et al., 2012; Brown et al., 2010).
Vector DNA concentrations were determined by a flourometric Qubit dsDNA
Broad Range assay kit (Life Technologies). Transfections were performed
with FugeneHD (Promega) transfection reagent. BIND Biosensor plates were
seeded with 10,000 HEK293T cells/well. 0.2 mg DNA and 0.6 ml FugeneHD
were diluted in 10 ml low serum OPTI-MEM medium (Life Technologies) for
15 min to allow DNA/FugeneHD complexes to form and added to HEK293T
seeded plates and incubated under 95% air/5% CO2 at 37
C for 48 hr.
Two-Electrode Voltage Clamp in Xenopus Oocytes
cRNA was created from Slack-B and mutant channel cRNA in pOX oocytes
expression vector with a mMessage mMachine T3 kit (Ambion) and aliquoted
in sterile water. Oocytes were isolated from Xenopus laevis frogs, injected with
50–100 ng of cRNA, and incubated in MND96 (Brown et al., 2010) at 18C
for up to 7 days before experiments were performed. Whole-oocyte currents
were measured by a two-electrode voltage clamp amplifier (OC-725C, Warner
Instruments). Electrodes were filledwith 3MKCl and had resistance 0.1–1MU.
Standard bath solution was MND96. Ooctyes were depolarized by 400-ms
pulses from a holding potential of 90 mV to test pulses of between 80
and +60 mV in 10-mV increments for 5 s. Data recording and analysis were
performed using pClamp (Molecular Devices), Excel (Microsoft), and Origin
8.1 (OriginLab Corporation) software packages.
BIND Scanner Assays
Poly-D-lysine/laminin-coated TiO2 384-well BIND biosensor plates were uti-
lized for all scanner assays. For HEK293 cell-based experiments, cells were
counted with a hemocytometer and plated at a density of 10,000 cells/well
in growthmedia and incubated for 24–48 hr. For primary cortical neuron-based
assays, neurons from postnatal day 2 or 3 male mice were prepared as
described (Brewer and Torricelli, 2007) and incubated for 7 days. After
7 days’ incubation, growth media was removed, and Hank’s balanced salt so-
lution (HBSS) with 0.1% DMSO was added. Cells were allowed to adjust to
room temperature for 1 hr before a baseline measurement was recorded.
Measurements were recorded at 3.75 mm/pixel resolution for the central
1.0-mm2 area of each well. Compounds or DMSO controls were added, and
30 min later a second measurement was recorded. A density gradient map
was generated for both records, and individual cells and the local background
selected utilizing BIND Scanner analysis software. The change in the index of
refraction for each cell and the local background as a function of the difference
between the first and second images was calculated. The change in index of
refraction for each cell was normalized to the local background, and a mean
value was calculated for each well. The change in peak wavelength of refrac-
tion was divided by the initial peak wavelength to give a physically relevant
change in the index of refraction. For primary cortical neuron experiments, ni-
closamide addition was normalized to DMSO vehicle alone addition. Results
were exported to Microsoft Excel and Origin Statistical Package for analysis.
Statistical Analysis
Data recording and analysis were performed using pClamp (Molecular De-
vices), Excel (Microsoft), Origin (Origin Lab Corporation), and BIND Scanner
and BIND View (X-BODY Biosciences). The mean ± SEM values are plotted.
Where two groups were compared, two-tailed Student’s t test was performed
to compare statistical significance; where three or more groups were
compared, one-way ANOVA test was performed.
See Supplemental Experimental Procedures for chemicals, cell culture, cre-
ation of mammalian expression vectors, animals, yeast two-hybrid assay,
RNAi against candidate Slack-B binding partners, cell viability assay, protein
purification of RNAi samples, co-immunopurification experiments, and west-
ern blotting, as well as detailed experimental procedures.
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